yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39681190-0758CEC6-226E-48EE-999B-208FE63D3D97
Q39681190-0758CEC6-226E-48EE-999B-208FE63D3D97
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-0758CEC6-226E-48EE-999B-208FE63D3D97
The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews.
P2860
Q39681190-0758CEC6-226E-48EE-999B-208FE63D3D97
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-0758CEC6-226E-48EE-999B-208FE63D3D97
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a9b4f5766232bb9e3e513a2ef0b48378db63a61
P2860
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease